Lv6
2000 积分 2024-12-24 加入
Triple G Agonists — A Home Run for Obesity?
14小时前
已完结
At ObesityWeek, More Data and Questions About Semaglutide, Tirzepatide, and Retatrutide
14小时前
已完结
Triple-Hormone Combination Retatrutide Induces 24% Body Weight Loss
14小时前
已完结
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
14小时前
已完结
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
14小时前
已完结
皖公网安备34019202002308
